AKR1C3 and non-small cell lung carcinoma: Moreover, in NSCLC, AKR1C3-mediated radioresistance may be linked to a decrease in G2/M phase arrest associated with radiation therapy and radiation-induced apoptosis (Xie et al., 2013).